Extubation in Pediatric Patients: Proactive or Passive?

January 28, 2023 updated by: Eye & ENT Hospital of Fudan University

Which is the Better Choice for Extubation in Pediatric Patients: Proactive or Passive?

Smooth extubation process can reduce the complications in recovery time. This study aimed to investigate what is the better time to extubation when children is breathing spontaneously and adequately: waiting until children have movements or wakefulness (passive extubation)or removing endotracheal tube directly (proactive tracheal extubation).

Study Overview

Status

Enrolling by invitation

Intervention / Treatment

Detailed Description

This is a randomized, controlled cross-over trial. The hypothesis of this study is that the different extubation protocol can impact recovery quality in children in post-anaesthesia care unit (PACU). Patients aged 3-7 years were randomized into two equal groups: proactive extubation (Group A) and passive extubation. At the end of surgery, sevoflurane was turned off and patients all delivered into PACU for recovery. Patient was positioned on his or her lateral side. The ventilation was switched to positive airway pressure (CPAP) mode once the patients regained spontaneous respiration. After spontaneous breathing turn to regular and sufficient(tidal volume >6-8 ml/kg, respiratory rate >10 times per minutes , end tidal carbon dioxide concentration >7.19 mmHg), the trachea tube could be removed. In Group A, patients were extubated in a light plane of anesthesia, when they are still asleep or have swallowing reflex. In Group B, tracheal extubation was performed when the patient regained consciousness, facial grimace, spontaneous eye opening, and purposeful arm movement. After extubation, 2 L/min oxygen was administered with Venturi face mask for 10 min in both groups. Patients were transported to the ward until they breathed air with a patent airway. The extubation time, recovery characteristics and respiratory complication were recorded.

Study Type

Interventional

Enrollment (Anticipated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Shanghai
      • Shanghai, Shanghai, China, 200031
        • Anesthesiology Department of Affiliated Eye and ENT Hospital, Fudan University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

3 years to 7 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • American Society of Anesthesiologists physical status aged 3-7 years

Exclusion Criteria:

  • a suspected difficult airway reactive airway disease, recent upper respiratory tract infection gastrointestinal reflux obesity (body mass index>30 kg/m2

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: group A
children were extubated in a light plane of anesthesia, when they are still asleep or have swallowing reflex.
when children is breathing spontaneously and adequately in PACU,endotracheal tube was removed directly
No Intervention: group B
Tracheal extubation was performed when the patient regained consciousness, facial grimace, spontaneous eye opening, and purposeful arm movement.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Coughing
Time Frame: at the time of extubation within 1 minute
1 if a single cough occurred and saturation by pulse oximetry (SpO2) ≥95%; 2 if multiple coughs occurred and SpO2 ≥95%; 3 if multiple coughs occurred and SpO2 <95%; and 4 if multiple coughs occurred, SpO2 <95%, and coughing required administration of i.v . medication.
at the time of extubation within 1 minute
Respiratory complications
Time Frame: During the time when patients stayed in PACU after extubation, an average of 45 min
the number of patients who had gagging, clenched teeth, gross purposeful movements, breath holding, laryngospasm, or desaturation to SpO2<90%
During the time when patients stayed in PACU after extubation, an average of 45 min
Time to spontaneous eye opening
Time Frame: The time from PACU arrival to spontaneous eye opening, an average of 45 min
Time to spontaneous eye opening
The time from PACU arrival to spontaneous eye opening, an average of 45 min
Time to discharge from PACU
Time Frame: The time from patients arrived PACU to who was decided to discharge from PACU,an average of 1 hour
Time to discharge from PACU
The time from patients arrived PACU to who was decided to discharge from PACU,an average of 1 hour

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Age
Time Frame: 6 hours before intervention
In years
6 hours before intervention
Height
Time Frame: 6 hours before intervention
In meters
6 hours before intervention
Time to extubation
Time Frame: The time from PACU arrival to tracheal extubation, an average of 30 min
The time of extubation after surgery
The time from PACU arrival to tracheal extubation, an average of 30 min
End-tidal concentration of minimum effective alveolar anesthetic concentration
Time Frame: The time before patients were decided to extubate, within 1 minute
In percentage
The time before patients were decided to extubate, within 1 minute
Weight
Time Frame: 6 hours before intervention
In kilograms
6 hours before intervention
Systolic blood pressure
Time Frame: 5 minutes before extubation
Hemodynamic parameter
5 minutes before extubation
Systolic blood pressure
Time Frame: 1 minute after extubation
Hemodynamic parameter
1 minute after extubation
Systolic blood pressure
Time Frame: 5 minutes after extubation
Hemodynamic parameter
5 minutes after extubation
Diastolic blood pressure
Time Frame: 5 minutes before extubation
Hemodynamic parameter
5 minutes before extubation
Diastolic blood pressure
Time Frame: 1 minute after extubation
Hemodynamic parameter
1 minute after extubation
Diastolic blood pressure
Time Frame: 5 minutes after extubation
Hemodynamic parameter
5 minutes after extubation
Heart rate
Time Frame: 5 minutes before extubation
hemodynamic parameter
5 minutes before extubation
Heart rate
Time Frame: 1 minute after extubation
hemodynamic parameter
1 minute after extubation
Heart rate
Time Frame: 5 minutes after extubation
hemodynamic parameter
5 minutes after extubation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 10, 2020

Primary Completion (Actual)

December 14, 2020

Study Completion (Anticipated)

April 1, 2024

Study Registration Dates

First Submitted

May 3, 2020

First Submitted That Met QC Criteria

June 13, 2020

First Posted (Actual)

June 16, 2020

Study Record Updates

Last Update Posted (Actual)

January 31, 2023

Last Update Submitted That Met QC Criteria

January 28, 2023

Last Verified

January 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • A/P extubation

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cough

Clinical Trials on proactive extubation

3
Subscribe